Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Bank Hapoalim BM

Bank Hapoalim BM trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.6% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 647 shares of the medical equipment provider’s stock after selling 200 shares during the period. Bank Hapoalim BM’s holdings in Intuitive Surgical were worth $318,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Valley National Advisers Inc. raised its holdings in Intuitive Surgical by 34.0% during the first quarter. Valley National Advisers Inc. now owns 481 shares of the medical equipment provider’s stock worth $191,000 after purchasing an additional 122 shares in the last quarter. Norden Group LLC grew its stake in shares of Intuitive Surgical by 2,441.2% during the 1st quarter. Norden Group LLC now owns 18,373 shares of the medical equipment provider’s stock worth $7,332,000 after purchasing an additional 17,650 shares during the period. Veracity Capital LLC purchased a new position in shares of Intuitive Surgical in the 1st quarter valued at about $243,000. Private Advisor Group LLC lifted its stake in shares of Intuitive Surgical by 9.1% in the first quarter. Private Advisor Group LLC now owns 11,873 shares of the medical equipment provider’s stock valued at $4,738,000 after purchasing an additional 987 shares during the period. Finally, Diversify Advisory Services LLC purchased a new stake in Intuitive Surgical during the first quarter worth about $2,862,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.7 %

Shares of ISRG traded down $3.36 on Thursday, reaching $510.41. 29,517 shares of the company’s stock were exchanged, compared to its average volume of 1,456,077. Intuitive Surgical, Inc. has a 12 month low of $260.17 and a 12 month high of $523.34. The stock has a market capitalization of $181.80 billion, a P/E ratio of 82.60, a price-to-earnings-growth ratio of 5.11 and a beta of 1.39. The business has a 50 day moving average price of $489.74 and a two-hundred day moving average price of $445.30.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amy L. Ladd sold 450 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now owns 821 shares of the company’s stock, valued at approximately $402,519.88. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,095 shares of company stock valued at $24,552,712 in the last 90 days. 0.80% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of analysts have commented on ISRG shares. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their target price for the company from $380.00 to $510.00 in a report on Friday, August 2nd. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup lifted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Piper Sandler restated an “overweight” rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.